Avid Bioservices Inc (CDMO)

[skweze]

Anything over $20 would be all hype, and will fall back into place when the day & swing traders exit. Sale potential for NSCLC can be readily quantified and SP will be reflective of that. What can really move the needle is partnering on all of the other IP that you mention. And if the company is still "going at it alone" when they get FDA approval, they will have BP suitors lining up at the door. All imo.

Eyebuy, with all due respect, your assumptions are at best worse case scenerio, short of failure of the Sunrise trial. I believe you are seriously under stating the market potential of Bavi. If Bavi gets approval, this stock seriously heads up well above $20, just on wall street hype alone and irregardless of what actual revenues would be. Also, highly doubt we will be much over 200 million shares by approval and i don't see approval taking until 2017....mid 2016 at worst and more likely a high chance of AA by end of next year. Partnerships will likely really come to fruition after first or second look in, so the need to raise more funding through ATM or preferred will likely end sometime next year. And remember, Sunrise is just for NSCLC, there are numerous applications beyond that and each has its own marketing potential. And with approval of one indication, AA might be easier with the other indications during earlier trial phases. And then when beta bodies are put into human trials, things will get even more interesting. In short, potential really is astronomical. However, i understand your frustration and it would appear that your enthusiasm has taken a big hit....ergo you are not as optimistic about making as much money in this stock than you used to be. Fear not brother, we are in good shape and on track....just a little more patience is required.